1. Home
  2. LEGN vs LPX Comparison

LEGN vs LPX Comparison

Compare LEGN & LPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LEGN
  • LPX
  • Stock Information
  • Founded
  • LEGN 2014
  • LPX 1973
  • Country
  • LEGN United States
  • LPX United States
  • Employees
  • LEGN N/A
  • LPX N/A
  • Industry
  • LEGN Biotechnology: Pharmaceutical Preparations
  • LPX Forest Products
  • Sector
  • LEGN Health Care
  • LPX Basic Materials
  • Exchange
  • LEGN Nasdaq
  • LPX Nasdaq
  • Market Cap
  • LEGN 6.3B
  • LPX 6.5B
  • IPO Year
  • LEGN 2020
  • LPX N/A
  • Fundamental
  • Price
  • LEGN $32.30
  • LPX $90.80
  • Analyst Decision
  • LEGN Strong Buy
  • LPX Buy
  • Analyst Count
  • LEGN 12
  • LPX 8
  • Target Price
  • LEGN $70.82
  • LPX $112.13
  • AVG Volume (30 Days)
  • LEGN 1.5M
  • LPX 719.5K
  • Earning Date
  • LEGN 11-11-2025
  • LPX 11-05-2025
  • Dividend Yield
  • LEGN N/A
  • LPX 1.23%
  • EPS Growth
  • LEGN N/A
  • LPX N/A
  • EPS
  • LEGN N/A
  • LPX 4.23
  • Revenue
  • LEGN $796,838,000.00
  • LPX $2,880,000,000.00
  • Revenue This Year
  • LEGN $70.27
  • LPX N/A
  • Revenue Next Year
  • LEGN $50.28
  • LPX $7.90
  • P/E Ratio
  • LEGN N/A
  • LPX $21.62
  • Revenue Growth
  • LEGN 74.75
  • LPX N/A
  • 52 Week Low
  • LEGN $27.34
  • LPX $78.82
  • 52 Week High
  • LEGN $47.79
  • LPX $122.87
  • Technical
  • Relative Strength Index (RSI)
  • LEGN 45.99
  • LPX 49.32
  • Support Level
  • LEGN $31.44
  • LPX $88.42
  • Resistance Level
  • LEGN $32.59
  • LPX $94.25
  • Average True Range (ATR)
  • LEGN 1.36
  • LPX 2.31
  • MACD
  • LEGN 0.11
  • LPX 0.19
  • Stochastic Oscillator
  • LEGN 37.97
  • LPX 40.86

About LEGN Legend Biotech Corporation

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

About LPX Louisiana-Pacific Corporation

Louisiana-Pacific is primarily an oriented strand board producer and also offers engineered wood siding used in home construction and repair and remodel projects. The company is largely exposed to the North American housing market but has also established capacity in Brazil and Chile.

Share on Social Networks: